Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are currently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $47.94.
Several analysts have recently issued reports on the stock. Mizuho dropped their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 14th. KeyCorp dropped their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Wall Street Zen upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday. Barclays dropped their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Finally, Guggenheim assumed coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 target price on the stock.
Check Out Our Latest Research Report on ACHC
Hedge Funds Weigh In On Acadia Healthcare
Acadia Healthcare Stock Down 1.9%
ACHC stock opened at $22.53 on Monday. The firm has a market cap of $2.08 billion, a PE ratio of 7.39, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s fifty day moving average is $25.70 and its 200 day moving average is $34.85. Acadia Healthcare has a one year low of $20.36 and a one year high of $82.41.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up .3% on a year-over-year basis. During the same quarter last year, the business earned $0.84 earnings per share. On average, research analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- Expert Stock Trading Psychology Tips
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Alphabet Stock LagsāBut Waymo May Be Its Hidden Driver
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.